AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 72 min read$WAT

KUEBLER CHRISTOPHER A sold $1.4M of WAT

KUEBLER CHRISTOPHER A sold 3,626 shares of WATERS CORP /DE/ (WAT) at $397.94 ($1.44M total) on 2026-08-06.

Original reporting
SEC EDGAR · KUEBLER CHRISTOPHER A
Published Aug 7, 2026, 9:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$WAT
Neutral
low confidence
Mentioned
$WAT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WATNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and post-transaction holdings. It may slightly affect sentiment, but it does not introduce new operational or financial information about Waters.

02

Market read

Traders may note insider selling, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The filing does not state a 10b5-1 plan, but it also provides no rationale for the sale, so interpreting it as bearish on fundamentals is speculative.

Relevance 6/10Novelty 3/10Timing: filed after-hours on Aug 7, transaction dated Aug 6

Background

The article is an SEC Form 4 insider transaction disclosure for Waters Corp, reported by director Christopher A Kuebler.

Company-level read

Ticker impact

$WATNeutralLow confidence
Context

Waters Corp director Christopher A Kuebler sold 3,626 shares in an open-market transaction valued at about $1.44M, per Form 4 filed Aug 7.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small unless follow-on selling accelerates.

Evidence & confidence

This is a routine Form 4 insider sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

Sector

No clear sector read-through from a single director sale filing.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales are often planned for diversification or liquidity needs; without evidence of broader selling, the signal may be overstated.

Key entities

  • issuer
    WATERS CORP /DE/

    Waters Corp, the company whose director insider sale is disclosed in the Form 4.

  • insider
    KUEBLER CHRISTOPHER A

    Director who sold 3,626 shares at $397.94/share, totaling about $1.44M.

Read at source← All news

Related articles

AUG 6
$WATMedAI 8/10

Waters Corporation Q2 2026 Earnings Call Summary

Waters Corp reported 9% organic constant-currency growth in Q2 2026, citing strength in pharma and academic end markets and a 400 bps growth acceleration in newly acquired Biosciences and Diagnostic Solutions. The company raised 2026 organic revenue guidance to 7-9%, expects acquired businesses to exit 2026 at 6%+ growth, and projects mid-teens adjusted EPS growth with margin expansion.

yahoo.com7 min
AUG 4
$WATHighAI 8/10

Why Waters Corporation (WAT) Stock Is Trading Up Today

Waters Corp (NYSE:WAT) shares rose about 5% after the company reported Q2 results that beat Wall Street and lifted full-year guidance. Waters posted adjusted EPS of $3.05 on revenue of $1.65B, with 7% organic growth. The company now expects 2026 adjusted earnings around $14.55 per share at the midpoint.

stockstory.org4 min
AUG 4
$WATMedAI 9/10

Waters Posts Loss In Q2; Raises 2026 Guidance

Waters Corporation (NYSE: WAT) reported a Q2 net loss of $136 million, versus net income of $147 million a year earlier. The company said Q2 GAAP results included non-GAAP EPS of $3.05 and revenue of $1.645 billion, above its guidance range. Waters also raised its 2026 guidance, according to its filings.

finanznachrichten.de4 min